Optimization of the cellular import of functionally active SH2-domain-interacting phosphopeptides

Cellular and Molecular Life Sciences

Volumn 63, Issue 22, 2006, Pages 2682-2693

  Kertesz A ^a   Varadi G ^b   Toth G K ^b   Fajka Boja, R ^c   Monostori, E ^c   Sarmay G ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF BIOCHEMISTRY   (Hungary)

Author keywords

Cell permeable peptide; Phosphopeptide; SH2 domain; Signaling; Tyrosine phosphorylation

Indexed keywords

ADAPTOR PROTEIN; ARGININE; FC RECEPTOR; FC RECEPTOR IIB; PHOSPHATASE; PHOSPHOPEPTIDE; PROTEIN GRB2; PROTEIN INHIBITOR; PROTEIN SH2; PROTEIN TYROSINE PHOSPHATASE SHP 2; TYROSINE; TYROSINE PHOSPHATASE 2; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CELL PERMEABILIZATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERMETHOD COMPARISON; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SHUTTLE VECTOR; SIGNAL TRANSDUCTION; TARGET CELL; TIME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID MOTIFS; B-LYMPHOCYTES; BURKITT LYMPHOMA; HUMANS; PERMEABILITY; PHOSPHOPEPTIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS;

EID: 33751302976     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-006-6346-6     Document Type: Article

References (61)

1. Tung, C. H. and Weissleder, R. (2003) Arginine containing peptides as delivery vectors. Adv. Drug Deliv. Rev. 55, 281-294.
2. Schwartz, J. J. and Zhang, S. (2000) Peptide-mediated cellular delivery. Curr. Opin. Mol. Ther. 2, 162-167.
3. Chitu, V., Demydenko, D., Toth, G. K., Hegedus, Z. and Monostori, E. (1999) Conditions for permeabilization of cells used for intracellular tyrosine phosphorylation studies. Biotechniques 27, 435-437.
4. Johnson, S. A., Pleiman, C. M., Pao, L., Schneringer, J., Hippen, K. and Cambier, J. C. (1995) Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases. J. Immunol. 155, 4596-4603.
5. Chitu, V., Fajka-Boja, R., Toth, G. K., Varadi, G., Hegedus, Z., Franko, A., Szucs, K. S. and Monostori, E. (2001) Comparative study on the effect of phosphorylated TCR zeta chain ITAM sequences on early activation events in Jurkat T cells. Peptides 22, 1963-1971.
6. Fischer, P. M., Krausz, E. and Lane, D. P. (2001) Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. Bioconjug. Chem. 12, 825-841.
7. Futaki, S. (2006) Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms. Biopolymers 84, 241-249.
8. Hawiger, J. (1999) Noninvasive intracellular delivery of functional peptides and proteins. Curr. Opin. Chem. Biol. 3, 89-94.
9. Joliot A P. A. (2004) Transduction peptides:from technology to physiology. Nat. Cell Biol. 6, 189-196.
10. Kueltzo, L. A. and Middaugh, C. R. (2000) Potential use of non-classical pathways for the transport of macromolecular drugs. Expert. Opin. Invest. Drugs 9, 2039-2050.
11. Morris, M. C., Vidal, P., Chaloin, L., Heitz, F. and Divita, G. (1997) A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 25, 2730-2736.
12. Vives, E., Brodin, P. and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017.
13. Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K. and Sugiura, Y. (2001) Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836-5840.
14. Daeron, M., Malbec, O., Latour, S., Espinosa, E., Pina, P. and Fridman, W. H. (1995) Regulation of tyrosine-containing activation motif-dependent cell signalling by Fc gamma RII. Immunol. Lett. 44, 119-123.
15. Koncz, G., Pecht, I., Gergely, J. and Sarmay, G. (1999) Fcgamma receptor-mediated inhibition of human B cell activation: the role of SHP-2 phosphatase. Eur. J. Immunol. 29, 1980-1989.
16. Sarmay, G., Koncz, G., Pecht, I. and Gergely, J. (1997) Fc gamma receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B cell. Immunol. Lett. 57, 159-164.
17. Sarmay, G., Koncz, G., Pecht, I. and Gergely, J. (1999) Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation. Immunol. Lett. 68, 25-34.
18. Famiglietti, S. J., Nakamura, K. and Cambier, J. C. (1999) Unique features of SHIP, SHP-1 and SHP-2 binding to FcgammaRIIb revealed by surface plasmon resonance analysis. Immunol. Lett. 68, 35-40.
19. Fong, D. C., Malbec, O., Arock, M., Cambier, J. C., Fridman, W. H. and Daeron, M. (1996) Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated Fc gammaRIIB during negative regulation of IgE-dependent mouse mast cell activation. Immunol. Lett. 54, 83-91.
20. Salmond, R. J. and Alexander, D. R. (2006) SHP-2 forecast for the immune system: fog gradually clearing. Trends Immunol. 27, 154-160.
21. Neel, B. G., Gu, H. and Pao, L. (2003) The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28, 284-293.
22. Zhang, S. Q., Tsiaras, W. G., Araki, T., Wen, G., Minichiello, L., Klein, R. and Neel, B. G. (2002) Receptor-specific regulation of phosphatidylinositol 3′-kinase activation by the protein tyrosine phosphatase SHP-2. Mol. Cell Biol. 22, 4062-4072.
23. Montagner, A., Yart, A., Dance, M., Perret, B., Salles, J. P. and Raynal, P. (2005) A novel role for Gab1 and SHP-2 in epidermal growth factor-induced Ras activation. J. Biol. Chem. 280, 5350-5360.
24. Bradshaw, J. M. and Waksman, G. (2002) Molecular recognition by SH2 domains. Adv. Protein Chem. 61, 161-210.
25. Moran, M. F., Koch, C. A., Anderson, D., Ellis, C., England, L., Martin, G. S. and Pawson, T. (1990) Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc. Natl. Acad. Sci. USA 87, 8622-8626.
26. Songyang, Z. and Cantley, L. C. (1995) Recognition and specificity in protein tyrosine kinase-mediated signalling. Trends Biochem. Sci. 20, 470-475.
27. Pawson, T. and Nash, P. (2000) Protein-protein interactions define specificity in signal transduction. Genes Dev. 14, 1027-1047.
28. Pawson, T., Gish, G. D. and Nash, P. (2001) SH2 domains, interaction modules and cellular wiring. Trends Cell Biol. 11, 504-511.
29. Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases. Cell 103, 211-225.
30. Zouali, M. and Sarmay, G. (2004) B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment. Arthritis Rheum. 50, 2730-2741.
31. Domchek, S. M., Auger, K. R., Chatterjee, S., Burke, T. R. Jr, and Shoelson, S. E. (1992) Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide. Biochemistry 31, 9865-9870.
32. Park, S. H., Won, J. and Lee, K. H. (2002) Design and characterization of non-phosphopeptide inhibitors for Src family SH2 domains. Bioorg. Med. Chem. Lett. 12, 2711-2714.
33. Turkson, J., Kim, J. S., Zhang, S., Yuan, J., Huang, M., Glenn, M., Haura, E., Sebti, S., Hamilton, A. D. and Jove, R. (2004) Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. Mol. Cancer Ther. 3, 261-269.
34. Merrifield, R. B. (2006) The synthesis of a tetrapeptide: solid phase peptide synthesis. J. Am. Chem. Soc. 85, 2149-2154.
35. Kaiser, E., Colescott, R. L. and Bossinger, C. D.and Cook, P. J. (1970) Color test for detection of free amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34, 595-598.
36. Tóth, G. K., Kelez, and Váradi, G. (2006). Phosphopeptides - chemical synthesis, analytics, outlook and limitations. Curr. Org. Chem. (in press).
37. Kupihar, Z., Varadi, G., Monostori, E. and Toth, G. K. (2000) Preparation of an asymmetrically protected phosphoramidite and its application in solid-phase synthesis of phosphopeptides. Tetrahedron Lett. 41, 4457-4461.
38. Cunnick, J. M., Mei, L., Doupnik, C. A. and Wu, J. (2001) Phosphotyrosines 627 and 659 of Gabi constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP-2. J. Biol. Chem. 276, 24380-24387.
39. Koncz, G., Toth, G. K., Bokonyi, G., Keri, G., Pecht, I., Medgyesi, D., Gergely, J. and Sarmay, G. (2001) Co-clustering of Fcgamtna and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein. Eur. J. Biochem. 268, 3898-3906.
40. Dunican, D. J. and Doherty, P. (2001) Designing cell-permeant phosphopeptides to modulate intracellular signaling pathways. Biopolymers 60, 45-60.
41. Li, P., Peach, M. L., Zhang, M., Liu, H., Yang, D., Nicklaus, M. and Roller, P. P. (2003) Structure-based design of thioether-bridged cyclic phosphopeptides binding to Grb2-SH2 domain. Bioorg. Med. Chem. Lett. 13, 895-899.
42. Liu, W. Q., Vidal, M., Mathe, C., Perigaud, C. and Garbay, C. (2000) Inhibition of the ras-dependent mitogenic pathway by phosphopeptide prodrugs with antiproliferative properties. Bioorg. Med. Chem. Lett. 10, 669-672.
43. Nam, N. H., Ye, G., Sun, G. and Parang, K. (2004) Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding. J. Med. Chem. 47, 3131-3141.
44. Nam, N. H., Pitts, R. L., Sun, G., Sardari, S., Tiemo, A., Xie, M., Yan, B. and Parang, K. (2004) Design of tetrapeptide ligands as inhibitors of the Src SH2 domain. Bioorg. Med. Chem. 12, 779-787.
45. Rojas, M., Yao, S. and Lin, Y. Z. (1996) Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J. Biol. Chem. 271, 27456-27461.
46. Liu, W. Q., Vidal, M., Mathe, C., Perigaud, C. and Garbay, C. (2000) Inhibition of the ras-dependent mitogenic pathway by phosphopeptide prodrugs with antiproliferative properties. Bioorg. Med. Chem. Lett. 10, 669-672.
47. Turkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., Laudano, A., Sebti, S., Hamilton, A. D. and Jove, R. (2001) Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J. Biol. Chem. 276, 45443-45455.
48. Cunnick, J. M., Meng, S., Ren, Y., Desponts, C., Wang, H. G., Djeu, J. Y. and Wu, J. (2002) Regulation of the mitogen-activated protein kinase signaling pathway by SHP-2. J. Biol. Chem. 277, 9498-9504.
49. Leibson, P. J. (2004) The regulation of lymphocyte activation by inhibitory receptors. Curr. Opin. Immunol. 16, 328-336.
50. Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T. and Honjo, T. (2001) PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA 98, 13866-13871.
51. Waterhouse, P., Marengere, L. E., Mittrucker, H. W. and Mak, T. W. (1996) CTLA-4, a negative regulator of T-lymphocyte activation. Immunol. Rev. 153, 183-207.
52. Yusa, S., Catina, T. L. and Campbell, K. S. (2004) KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2). J. Immunol. 172, 7385-7392.
53. Yusa, S. and Campbell, K. S. (2003) Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells. J. Immunol. 170, 4539-4547.
54. Newman, D. K., Hamilton, C. and Newman, P. J. (2001) Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood 97, 2351-2357.
55. Henshall, T. L., Jones, K. L., Wilkinson, R. and Jackson, D. E. (2001) Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling. J. Immunol. 166, 3098-3106.
56. Futaki, S., Ohashi, W., Suzuki, T., Niwa, M., Tanaka, S., Ueda, K., Harashima, H. and Sugiura, Y. (2001) Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug. Chem. 12, 1005-1011.
57. Pooga, M., Kut, C., Kihlmark, M., Hallbrink, M., Fernaeus, S., Raid, R., Land, T., Hallberg, E., Bartfai, T. and Langel, U. (2001) Cellular translocation of proteins by transportan. FASEB J. 15, 1451-1453.
58. Simeoni, F., Morris, M. C., Heitz, F. and Divita, G. (2003) Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 31, 2717-2724.
59. Soomets, U., Lindgren, M., Gallet, X., Hallbrink, M., Elmquist, A., Balaspiri, L., Zorko, M., Pooga, M., Brasseur, R. and Langel, U. (2000) Deletion analogues of transportan. Biochim. Biophys. Acta 1467, 165-176.
60. Nakase, I., Niwa, M., Takeuchi, T., Sonomura, K., Kawabata, N., Koike, Y., Takehashi, M., Tanaka, S., Ueda, K., Simpson, J. C. et al. (2004) Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol. Ther. 10, 1011-1022.
61. Hudecz, F., Banoczi, Z. and Csik, G. (2005) Medium-sized peptides as built in carriers for biologically active compounds. Med. Res. Rev. 25, 679-736.